Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

life_healthcare_jpg

Life Healthcare makes four new appointments

November 16, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life healthcare communications

Life Healthcare Communications has made four new appointments, adding to its client service, creative and digital teams. Vicki Marsh joins …
Appointment

Is global consistency in GCP interpretation an achievable goal?

November 16, 2011 Research and Development

The potential benefits of standardisation in the conduct of an increasingly global clinical research effort are enormous. The promise of …
Feature
Thought Leadership

Quicker and slicker: new initiatives to improve clinical trial delivery

November 16, 2011 Research and Development

Faster study set-up times, reduced bureaucracy and timely patient recruitment – these things are central to the success of commercial …
Feature
Thought Leadership

Infectious diseases versus clinical researchers. Who is winning?

November 16, 2011 Research and Development

They were running hand in hand, and the Queen went so fast that it was all she could do to …
Feature
Thought Leadership

Full service CROs: a cost-effective option for global therapeutically focused clinical development expertise

November 16, 2011 Research and Development

Skyrocketing clinical development costs are bad news for everyone, from pharmaceutical companies to patients. That’s why it’s crucial we find …
Feature
Thought Leadership

Emerging markets: comparing India and China as the future R&D hubs for the pharmaceutical industry

November 16, 2011 Research and Development

The pharmaceutical industry is expanding worldwide. For the last few years, the emerging markets that offer the dynamics of growth …
Feature
Thought Leadership
Boehringer pic

Boehringer invests $65 million in early R&D centre

November 16, 2011 Research and Development, Sales and Marketing Boehringer Ingelheim

Boehringer Ingelheim is investing $65 million for an early-stage research and development centre in the US. The new 72,000 sq.ft. …
News

Pharmacovigilance in the EU – recent and future changes

November 15, 2011 Research and Development

Changes to both post-marketing and clinical trial requirements
Feature
Thought Leadership

The roles and responsibilities of an EEA qualified person for pharmacovigilance (QPPV)

November 15, 2011 Research and Development

The roles and responsibilities of an EEA Qualified Person for Pharmacovigilance are based on the current Directive 2001/83/EC and Vol …
Feature
Thought Leadership

Joachim Christ to lead corporate controlling at Merck KGaA

November 15, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA

Joachim Christ will join Merck KGaA on 1 January next year as its new head of corporate controlling. Christ, 46, …
Appointment

Sanofi’s Lemtrada beats Rebif in new study

November 14, 2011 Research and Development, Sales and Marketing Lemtrada, Rebif, Sanofi

Lemtrada has beaten Merck Serono’s multiple sclerosis treatment Rebif in a new head-to-head trial, paving the way for regulatory submission …
News
mark_greener_21

Mark Greener appointed editorial director at Rock Medical Communications

November 14, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mark Greener, Rock Medical Communications

Rock medical communications has appointed journalist and medical writer Mark Greener as editorial director.  Mark spent a decade in the …
Appointment

The ABPI’s new leader: communicating pharma’s value

November 14, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Stephen Whitehead

When Richard Barker, the ABPI’s director general decided to step down in May this year after six and a half …
Feature

Eliquis fails in head-to-head study against Lovenox

November 14, 2011 Research and Development, Sales and Marketing BMS, Eliquis, Lovenox, Pfizer

Bristol-Myers Squibb and Pfizer have suffered a setback in their attempts to cement Eliquis’ place in the $20 billion market …
News

Genzyme appoints new leaders for multiple sclerosis and rare disease businesses

November 14, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genzyme

Genzyme, a Sanofi company, has appointed William Sibold as head of multiple sclerosis and Rogério Vivaldi as head of rare …
Appointment
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026